SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-089548
Filing Date
2023-08-10
Accepted
2023-08-10 07:07:41
Documents
14
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323263d1_8k.htm   iXBRL 8-K 24784
2 EXHIBIT 99.1 tm2323263d1_ex99-1.htm EX-99.1 75628
6 GRAPHIC tm2323263d1_ex99-1img001.gif GRAPHIC 4699
  Complete submission text file 0001104659-23-089548.txt   293613

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aplt-20230810.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20230810_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20230810_pre.xml EX-101.PRE 22381
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2323263d1_8k_htm.xml XML 3386
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 231157150
SIC: 2834 Pharmaceutical Preparations